38.00
-0.80
(-2.06%)
As of 8:28:05 AM GMT+1. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 13 | 9 | 13 | 13 |
| Avg. Estimate | 346.15k | -- | 346.15k | 1.38M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | 4.5M | -- | 4.5M | 18M |
| Year Ago Sales | 742k | -- | 11.58M | 346.15k |
| Sales Growth (year/est) | -53.35% | 0.00% | -97.01% | 300.01% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 42Z.F | -- | -- | -- | -- |
| S&P 500 | 9.90% | 11.00% | 14.01% | 13.54% |
Upgrades & Downgrades
| Maintains | UBS: Buy to Buy | 1/8/2025 |
| Maintains | Wedbush: Outperform to Outperform | 12/6/2024 |
| Maintains | Needham: Buy to Buy | 12/6/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 12/4/2024 |
| Maintains | Guggenheim: Buy to Buy | 12/3/2024 |
| Reiterates | Needham: Buy to Buy | 12/3/2024 |
Related Tickers
ISI.MU Ionis Pharmaceuticals Inc
32.86
0.00%
2GH.MU Merus NV
39.00
0.00%
RGO.DU Regeneron Pharmaceuticals Inc
632.40
-3.89%
C17.F Corvus Pharmaceuticals, Inc.
4.8800
-1.21%
RGO.MU Regeneron Pharmaceuticals Inc
644.40
-0.89%
BH3.F PTC Therapeutics, Inc.
42.80
-1.83%
4DN.F Denali Therapeutics Inc.
20.90
-5.43%
4DN.BE Denali Therapeutics Inc
20.97
-1.50%
IONS.MX Ionis Pharmaceuticals, Inc.
673.00
0.00%
ISI.BE Ionis Pharmaceuticals Inc
32.70
0.00%